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ABSTRACT
Development of novel aptamer sensor strategies for
rapid and selective assays of protein biomarkers
plays crucial roles in proteomics and clinical diag-
nostics. Herein, we have developed a novel aptamer
sensor strategy for homogeneous detection of
protein targets based on fluorescence protection
assay. This strategy is based on our reasoning
that interaction of aptamer with its protein target
may dramatically increase steric hindrance,
which protects the fluorophore, fluorescein
isothiocyannate (FITC), labeled at the binding
pocket from accessing and quenching by the FITC
antibody. The aptamer sensor strategy is
demonstrated using a model protein target of im-
munoglobulin E (IgE), a known biomarker
associated with atopic allergic diseases. The
results reveal that the aptamer sensor shows sub-
stantial (>6-fold) fluorescence enhancement in
response to the protein target, thereby verifying
the mechanism of fluorescence protection.
Moreover, the aptamer sensor displays improved
specificity to other co-existing proteins and a desir-
able dynamic range within the IgE concentration
from 0.1 to 50nM with a readily achieved detection
limit of 0.1nM. Because of great robustness, easy
operation and scalability for parallel assays, the de-
veloped homogeneous fluorescence protection
assay strategy might create a new methodology
for developing aptamer sensors in sensitive, select-
ive detection of proteins.
INTRODUCTION
Rapid and selective assays of protein biomarkers play
crucial roles in proteomics and clinical diagnostics.
Such assays are typically started using certain afﬁnity
ligands such as antibodies and aptamers that speciﬁcally
interact with the protein targets. Then, the molecular rec-
ognition events are detected via a cascade of signal trans-
duction to render target-speciﬁc responses. Classic protein
detection strategies include enzyme-linked immunosorb-
ent assays, protein microarrays (1), magnetic-separation
assay (2), lateral-ﬂow assay (3,4) and biosensors (5,6).
These techniques commonly rely on immobilization of
the biomolecular ligands to the protein targets.
Although technically endowed with the capacity of multi-
plexed assay of multiple targets, these surface-based
methods may interfere with interactions between the
target proteins and the biomolecular ligands, thus
requiring cautious washing and blocking to combat
non-speciﬁc adsorption. Homogeneous assay such as
ﬂuorescence polarization (7), ﬂuorescence resonant
energy transfer (8,9) and protein-fragment complementa-
tion (10), which can be implemented without any surface
operations, then offers a rapid, selective and robust tech-
nology for the detection of protein biomarkers.
Aptamers are short single-stranded oligonucleotides
selected for their high afﬁnity to certain targets (11,12).
Compared with conventional biomolecular ligands as
antibodies, aptamer-based ligands may exhibit prominent
advantages such as site-speciﬁc labeling, structure-
controlled design and sequence-dependent ampliﬁcation,
which makes them an ideal molecular recognition tool
for biomedical detection and biosensor developments
(13,14). In the context, the development of aptamer
sensors with unique response strategies for homogeneous
assays has been a subject of intensive interest, besides the
proliferated uses of aptamers in place of antibodies in es-
tablished immunoassay techniques (15). Aptamers often
undergo conformational changes on interacting with
their cognate targets, which renders a generic homoge-
neous assay strategy for the construction of aptamer
sensors (16,17). Adaptive binding of aptamers to the
targets is possible to displace a complementary sequence
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switching strategy creates another useful homogeneous
assay platform for aptamer sensors (18,19). On the other
hand, aptamer sensors may be devised based on
re-assembly of two split aptamer subunits as a result of
aptamer–target interactions (20,21). Alternatively,
aptamer sensors can be constructed for homogeneous
assays based on proximity-dependent hybridization of
two aptamer probes simultaneously interacting with
target proteins (22,23). Apart from these response
strategies, aptamer recognition can be readily combined
with nucleic acid-based enzymatic treatments for down-
stream signal transduction or ampliﬁcation in aptamer
sensors (24–27). For example, aptamer recognition could
result in the formation of a folded hairpin structure, from
which a signal-reporting DNA sequence was ampliﬁed via
nickase-based strand displacement ampliﬁcation (24),
target-mediated strand displacement ampliﬁcation (25)
or rolling circle ampliﬁcation (26,27).
Herein, we report a novel aptamer sensor strategy for
homogeneous ﬂuorescence detection of protein targets.
This strategy is based on the inhibition of antibody-
induced quenching of ﬂuorescein isothiocyannate (FITC)
label by binding of aptamer to its protein target. Because
interferences from non-speciﬁcally interacting proteins
could be precluded by competitive interaction of
antibody–FITC, this strategy possesses improved speciﬁ-
city as compared with other aptamer sensor strategies.
Moreover, it is possible to adjust the resistance to
non-speciﬁc interactions via selection of antibodies with
varying binding afﬁnities. Furthermore, the developed
technique is implemented in homogeneous format with
no need of washing and separation steps. This makes the
assays more robust, easily automated, scalable for parallel
assays of patient samples, as desired in clinical applica-
tions. As a proof-of-principle, the strategy was
demonstrated using a model protein target of immuno-
globulin E (IgE), a known biomarker associated with
atopic allergic diseases (28).
MATERIALS AND METHODS
Chemicals and materials
IgE, monoclonal antibody to FITC were purchased from
Sigma Aldrich Chemical Co. Human serum albumin
(HSA), immunoglobulis G (IgG), lysozyme, thrombin,
a-fetoprotein (AFP), hemoglobin and carcinoembryonic
antigen (CEA), bovine serum were obtained from
Dingguo Biotech. Co. (Beijing, China). All other chem-
icals were of analytical grade and obtained from
Sinopharm Chemical Reagent Co. All solutions were
prepared using ultrapure water, which was obtained
through a Millipore Milli-Q water puriﬁcation system
(Billerica, MA, USA) and had an electric resistance
>18.3M. DNA aptamer against IgE was designed to
have the following sequence: 50-GCG CGG GGC ACG
TTT ATC CGT CCC TCC TAG TGG CGT GCC CCG
CGC-30, and the FITC labeling sites are given in
Figure 2A. A control DNA was designed to have the
following sequence: 50-ATG TAA GAG GTT TCA
TAT(-FITC) TGC TAA TAG CAG CTA CAA TCC
AGC TAC-30. All oligonucleotides were synthesized
from Takara Biotechnology Co. Ltd. (Dalian, China).
Thermodynamic parameters and secondary structures of
all oligonucleotides were calculated using bioinformatics
software (http://mfold.rna.albany.edu/).
Fluorescence protection assay of IgE
A 50-ml aliquot of reagent solution containing a
FITC-labeled aptamer probe (20nM) in a binding buffer
(8mM Na2HPO4, 1mM KH2PO4, 1mM MgCl2,3 m M
KCl and 150mM NaCl, pH 7.4) was added in a given
sample (50ml, ﬁnal IgE concentrations ranging from 0 to
50nM with other protein concentration otherwise
speciﬁed). The mixture was incubated at room tempera-
ture for 10min to allow complete interaction between
aptamer and IgE. Then, 5ml antibody to FITC
(18.5mM) was added in the mixture and incubated for
another 10min to perform the immunoreaction. The re-
sulting solution was immediately subjected to ﬂuorescence
measurements. The ﬂuorescence spectra were recorded at
room temperature in a quartz cuvette on an F-7000
spectroﬂuorometer (Hitachi, Japan). The excitation wave-
length was 490nm and the emission wavelengths were in
the range from 510 to 610nm with both excitation and
emission slits of 5nm.
Fluorescence anisotropy assay of aptamer–IgE interaction
The ﬂuorescence anisotropy response of the aptamer
probe was measured directly using 10nM FITC-labeled
aptamer solution. The aptamer–IgE complex was
prepared by adding 50ml reagent solution in 50ml IgE
solution (ﬁnal concentration of IgE and aptamer were 20
and 10nM, respectively) followed by incubation at room
temperature for 10min. The resulting mixture was directly
taken to measure the ﬂuorescence anisotropy response of
aptamer–IgE complex. Then, 5ml antibody to FITC
(18.5mM) was added in the mixture and incubated for
another 10min. Again, the ﬂuorescence anisotropy
response of the mixture was measured. The complex
between antibody and FITC-labeled aptamer was
prepared by adding 50ml reagent solution, 50ml ultrapure
water and 5ml FITC antibody (18.5mM) followed by in-
cubation at room temperature for 10min. The resulting
mixture was used to measure the ﬂuorescence anisotropy
response of complex between antibody and FITC-labeled
aptamer. The ﬂuorescence anisotropy measurements were
performed at room temperature in a quartz cuvette on a
FL3-P-TCSPC ﬂuorescence spectrophotometer (Jobin
Yvon, France). The excitation wavelength was 490nm
and the emission wavelengths were in the range from
510 to 580nm with both excitation and emission slits of
5nm.
Capillary electrophoresis assay of aptamer–IgE
interaction
All samples as prepared in ﬂuorescence anisotropy assay
were subjected to capillary electrophoresis assay. The ca-
pillary electrophoresis experiment was performed using
a capillary electrophoresis system equipped with UV
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under an applied potential of 20kV using a quartz capil-
lary with 75mm diameter (total length, 50cm; effective
length, 30cm) in 50mM borate running buffer (pH 9.2).
Samples were injected into the capillary using the pressure
injection mode at 0.5psi for 5s and detected at 254nm for
30min. The temperature of the separation, 25 C, was
controlled by immersion of the capillary in a cooling
liquid circulating in the cartridge. Between successive
runs, the capillary was rinsed with ultrapure water and
running buffer for 5min, respectively.
RESULTS AND DISCUSSION
Analytical principle of ﬂuorescence protection assay-based
aptamer sensor
This developed aptamer sensor strategy relied on protec-
tion of ﬂuorophores against antibody-induced quenching
upon aptamer–protein binding, as illustrated in Figure 1.
A ﬂuophore is labeled in proximity to the target-binding
site of the aptamer. In the absence of IgE target, the
ﬂuophore antibody is able to bind to the ﬂuophore
moiety, efﬁciently quenching the ﬂuorescence of the
ﬂuophore. Upon binding of aptamer to its protein
target, the big size of proteins (with reference to
aptamer) can dramatically increase steric hindrance at
the ﬂuophore site. This prevents the big size antibody
from interacting the ﬂuophore, resulting in the protection
of ﬂuorescence from antibody-based quenching. It is
known that there are some ﬂuophores with ﬂuorescence
efﬁciently quenched by their antibodies (29,30).
Preferentially, FITC can be chosen as the ﬂuophore
because of its high ﬂuorescence response and high
quenching efﬁciency obtained when bound by ﬂuorescein
antibody (31).
It is noteworthy that the developed strategy simply
utilizes the fact that after binding of protein target to
aptamer, steric hindrance at the binding pocket will be
increased substantially such that the sites at the binding
pocket cannot be accessed to other macromolecules as
antibody. This mechanism is conceptually straightforward
and, to our knowledge, is innovative with comparion to
existing four unique mechanisms for aptamer sensors
(16–23). Speciﬁcally, it is also substantially different
from other IgE aptamser sensors reported previously
(32,33), which are essentially based conformational
changes of the aptamer probes induced by aptamer–IgE
binding. For example, it was supposed that the free-state
aptamer exhibits a sticky-end pairing dimeric duplex con-
formation in the absence of IgE, while, on binding to IgE,
the aptamer changed its conformation into a stem–loop
secondary structure. This inhibited the cross-linking of
gold nanoparticles by the thiolated dimeric duplex, thus
rendering a light-up colorimetric sensor for IgE (32).
Probe design and optimization of label sites on
aptamer sequence
The aptamer against IgE comprised a 45-nt
hairpin-structured DNA sequence with a 4-bp extension
in the stem region as shown in Figure 2A, which was
reported to improve its afﬁnity to IgE target (37). Like
other aptamer sensor strategies requiring sequence opti-
mization (14–22), the FITC ﬂuorophore should be
optimized to be labeled in adjacency to the aptamer–
protein binding site in order to obtain ﬂuorescence pro-
tection against antibody-induced quenching. Because
DNA synthesis had been able to incorporate various
FITC-modiﬁed nucleotides at any site of a DNA
sequence, we designed aptamer probes with FITC label
at different sites to screen for the location with desired
ﬂuorescence protection characteristics.
Figure 2B depicts ﬂuorescence spectral responses of
aptamer probes with FITC labeled at three distinct sites.
In the absence of IgE and FITC antibody, strong ﬂuores-
cence peaks were observed for these aptamer probes. After
incubated with antibody to FITC, these aptamer probes
Figure 2. (A) Secondary structure of the IgE DNA aptamer used in the
experiments. Three sites at T nucleotide for FITC labeling are
symbolized in red numbers. (B) Typical ﬂuorescence spectra measured
for IgE aptamer (10nM) with FITC label at three different sites in
response to 0.88mM FITC antibody (Ab) and 40nM IgE plus
0.88mM FITC Ab.
Figure 1. Fluorescence protection assay strategy for aptamer sensor.
Fluorophore label (green star) on free aptamer binds to its antibody
giving quenched ﬂuorescence. Interaction of protein with aptamer
prevents antibody from binding to ﬂuorophore, strong ﬂuorescence
recovered.
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intensity compared to that for free aptamer probes), indi-
cators of efﬁcient ﬂuorescence quenching by FITC
antibody for free aptamer probes. Interestingly, for
aptamer probe with FITC label at Site 1, incubation of
aptamer probe with IgE followed by FITC antibody was
observed to give a strong ﬂuorescenc peak with
 90% intensity retained. This signal was substantially
enhanced (>6-fold) with reference to the antibody-
quenched ﬂuorescence. Though a ﬂuorescence decrease
still appeared because of the equilibrium between
aptamer–IgE complexes and free aptamers with a dissoci-
ation constant  3.6nM (37), this ﬁnding implied that
binding antibody to FITC was substantially inhibited by
aptamer–IgE interaction, an immediate evidence for ﬂuor-
escence protection. In contrast, for aptamer probes with
FITC at Site 2 after incubation with IgE followed by
FITC antibody, we observed a very weak ﬂuorescence
peak, its intensity approximating to those for free
aptamer probes directly quenched by FITC antibody.
This suggested that aptamer–IgE interaction almost had
no effect on the binding of antibody to FITC at Site 2. Site
3 was an intermediate case between Sites 1 and 2 for which
the ﬂuorescence peak was between those of Sites 1 and 2
after the aptamer probe incubated with IgE followed by
FITC antibody. This might be attributed to a decrease
of binding afﬁnity to IgE for the aptamer with FITC at
Site 3. Combining these observations, we obtained that
aptamer probe with FITC at Site 1 exhibited a desirable
response characteristic for our ﬂuorescence protection
assay strategy. Hence, this aptamer probe was used for
subsequent studies.
Typical characteristics of ﬂuorescence protection assay-
based aptamer sensor
A close inspection of interactions between the aptamer
probe and IgE together with FITC antibody was per-
formed using capillary electrophoresis analysis as shown
in Figure 3. It was noticed that after incubated aptamer
probe with IgE or FITC antibody, a new peak appeared at
an increased migration time with concomitant decreases in
electrophoretic peaks for free aptamer or proteins. This
indicated that aptamer probe was bound to IgE or
FITC antibody, both increasing the frictional drag of
aptamer and exhibiting a prolonged migration time
(34,35). Intriguingly, after addition of FITC antibody in
the mixture of aptamer and IgE, only the free aptamer
peak disappeared accompanying with the appearance of
a peak for FITC antibody-bound aptamer, the aptamer–
IgE complex peak remaining unaltered with no new peak
emerging accordingly. This ﬁnding disclosed that
aptamer–IgE interaction could inhibit the binding of
antibody conﬁrming our hypothesis of ﬂuorescence
protection.
A further investigation of interactions between the
aptamer probe and IgE together with FITC antibody
was performed using ﬂuorescence anisotropy analysis as
shown in Figure 4. It is observed that after incubated with
IgE or FITC Ab, the aptamer probe showed appreciable
rises in ﬂuorescence anisotropy responses, indicating the
formation of aptamer–IgE or antibody FITC-labeled
aptamer complex with substantially increased molecular
weights. Intriguingly, no further appreciable ascent of
ﬂuorescence anisotropy responses was obtained after the
IgE-bound aptamer probe incubated with FITC antibody,
revealing that there was no substantial change in the mo-
lecular weight for the major ﬂuorescence component,
aptamer–IgE complex. Thus, this ﬁnding actually
disclosed that aptamer–IgE interaction could inhibit the
binding of antibody to FITC label.
Quantitative analysis of IgE using ﬂuorescence protection
assay-based aptamer sensor
Figure 5 depicts typical ﬂuorescence spectral responses of
the aptamer sensor to IgE of varying concentrations. One
observed dynamically increased ﬂuorescence peaks with
increasing IgE concentration ranging from 0.1 to 50nM.
A quasilinear response was obtained in the concentration
range from 1.0 to 40nM with a readily achieved detection
Wavelength/nm
500 520 540 560 580
A
n
i
s
o
t
r
o
p
y
0.0
.2
.4
.6
.8
0
0
0
0
Aptamer
Aptamer+IgE
Aptamer+Ab
Aptamer+IgE+Ab
Figure 4. Fluorescence anisotropy proﬁles obtained in 510nm through
580nm for 10nM FITC-labeled aptamer, mixture of 10nM
FITC-labeled aptamer and 0.88mM FITC antibody, mixture of
10nM FITC-labeled aptamer and 20nM IgE, and mixture of 10nM
FITC-labeled aptamer and 20nM IgE with later addition of 0.88mM
FITC antibody.
Figure 3. Capillary electrophoretograms obtained with 180nM IgE,
150nM aptamer, 0.88mM FITC Ab and their mixtures.
e122 Nucleic Acids Research, 2011,Vol.39, No. 18 PAGE 4 OF 7limit of 0.1nM. Such detection sensitivity was adequate
for routine clinical applications (36), and was comparable
to many exisitng homogenous assay techniques for IgE
detection (33,38). Because of its homogeneous assay
format, the strategy also exhibited excellent reproducibil-
ity, ﬂuorescence peak readouts showing relative standard
deviations of 3.7, 5.1 and 4.5% in four repetitive assays
of 1, 10 and 40nM IgE, respectively.
A major advantage of ﬂuorescence protection assay was
its high resistance to non-speciﬁc interactions of proteins
with aptamer probe. As shown in Figure 6, it was
observed that the aptamer sensor yielded very weak ﬂuor-
escence signals in response to other proteins such as HSA,
IgG, lysozyme, thrombin, AFP, CEA, which contrasted
clearly with the strong ﬂuorescence response to IgE. In a
control experiment using a DNA probe with sequence dif-
ferent from the aptamer, we also obtained very small
ﬂuorescence peak, implying that ﬂuorescence protection
was speciﬁcally originated from the interaction of
aptamer with IgE protein. Notably, ﬂuorescence responses
to bovine serum with and without IgE exhibited only
slight discrepancies from those for IgE in the buffer and
for the blank, respectively. This revealed excellent select-
ivity of ﬂuorescence protection assay, which might
support its potential in clinical applications. As a matter
of fact, the ﬂuorescence protection assay involved two
competitive interactions, FITC with its antibody and
aptamer with target protein. If non-speciﬁc interactions
showed faster dissociation kinetics than that for
FITC-antibody complex, binding of antibody to FITC
could become dominant in the competition, thereby
allowing eliminating the interferences from
non-speciﬁcally interacting proteins in ﬂuorescence pro-
tection assay.
CONCLUSION
We developed a novel ﬂuorescence protection assay
strategy toward aptamer sensors for homogeous detection
of IgE. This strategy relied on inhibition of
antibody-induced quenching of FITC label by aptamer–
IgE binding. Because interferences from non-speciﬁcally
interacting proteins could be precluded by competitive
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improved speciﬁcity as compared with other aptamer
sensor strategies (16–22). Moreover, it was possible to
adjust the resistance to non-speciﬁc interactions via selec-
tion of antibodies with varying binding afﬁnities. The
method could be applied directly to detecting other
proteins by use of corresponding aptamers through opti-
mization of the FITC labeling site. Also, the strategy
could be implemented for multiplex detection of multiple
proteins by using different ﬂuorophore labels with non-
overlapping emission peaks, provided that their quenching
antibodies were available (29,30). Because of its homoge-
neous assay format, this technique could show great ro-
bustness, easy operation and scalability for parallel assays
of hundreds of samples. In view of these advantages, the
ﬂuorescence protection assay strategy might create a new
methodology for developing sensitive, selective aptamer
sensors in homogeneous detection of proteins.
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